These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24718394)

  • 21. How genomics is contributing to the fight against artemisinin-resistant malaria parasites.
    Cravo P; Napolitano H; Culleton R
    Acta Trop; 2015 Aug; 148():1-7. PubMed ID: 25910626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amazonian plant natural products: perspectives for discovery of new antimalarial drug leads.
    Pohlit AM; Lima RB; Frausin G; Silva LF; Lopes SC; Moraes CB; Cravo P; Lacerda MV; Siqueira AM; Freitas-Junior LH; Costa FT
    Molecules; 2013 Aug; 18(8):9219-40. PubMed ID: 23917112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti.
    Vincent JP; Komaki-Yasuda K; Existe AV; Boncy J; Kano S
    Emerg Infect Dis; 2018 Nov; 24(11):2124-2126. PubMed ID: 30334724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A brief history of artemisinin: Modes of action and mechanisms of resistance.
    Lu F; He XL; Richard C; Cao J
    Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 27. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
    Quashie NB; Duah NO; Abuaku B; Koram KA
    Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revising antimalarial drug policy in Central America: experience in Panama.
    Calzada JE; Samudio F; Bayard V; Obaldia N; de Mosca IB; Pascale JM
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):694-8. PubMed ID: 18436272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance genomics of the antimalarial drug artemisinin.
    Winzeler EA; Manary MJ
    Genome Biol; 2014 Nov; 15(11):544. PubMed ID: 25470531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of antimalarial drugs].
    Tanabe K; Shimada K
    Kansenshogaku Zasshi; 1990 Jun; 64(6):668-73. PubMed ID: 2205671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance in malaria.
    Farooq U; Mahajan RC
    J Vector Borne Dis; 2004; 41(3-4):45-53. PubMed ID: 15672556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
    Zhou LJ; Xia J; Wei HX; Liu XJ; Peng HJ
    Parasitol Res; 2017 Feb; 116(2):781-788. PubMed ID: 28028628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.
    Oladipo OO; Wellington OA; Sutherland CJ
    Diagn Pathol; 2015 Apr; 10():41. PubMed ID: 25928117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India.
    Kaur H; Sehgal R; Kumar A; Bharti PK; Bansal D; Mohapatra PK; Mahanta J; Sultan AA
    BMC Infect Dis; 2020 Sep; 20(1):671. PubMed ID: 32933490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.
    Mehlotra RK; Henry-Halldin CN; Zimmerman PA
    Pharmacogenomics; 2009 Mar; 10(3):435-49. PubMed ID: 19290792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine and artemisinin: six decades of research--what next?
    Delhaes L; Benoit-Vical F; Camus D; Capron M; Meunier B
    IDrugs; 2003 Jul; 6(7):674-80. PubMed ID: 12861472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in antimalarial drug use in Africa.
    Flegg JA; Metcalf CJE; Gharbi M; Venkatesan M; Shewchuk T; Hopkins Sibley C; Guerin PJ
    Am J Trop Med Hyg; 2013 Nov; 89(5):857-865. PubMed ID: 24019436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the antimalarial potential of tetraoxane WR 148999.
    Vennerstrom JL; Ager AL; Andersen SL; Grace JM; Wongpanich V; Angerhofer CK; Hu JK; Wesche DL
    Am J Trop Med Hyg; 2000 May; 62(5):573-8. PubMed ID: 11289666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.